Hyperglycemia Alters Refractory Periods in Human Diabetic Neuropathy
Overview
Psychiatry
Affiliations
Objective: To investigate the effects of hyperglycemia on axonal excitability in human diabetics. Diabetic nerve dysfunction is partly associated with the altered polyol pathway and Na+-K+ ATPase activity, probably resulting in a decrease in the trans-axonal Na+ gradient and reduced nodal Na+ currents.
Methods: Threshold tracking was used to measure the relative refractory periods (RPs) of median motor axons in 58 diabetic patients, 45 normal subjects, and 12 patients with non-diabetic axonal neuropathy. In diabetic patients, the relationship of RPs with hemoglobin A1c (HbA1c) levels was analyzed.
Results: The mean RP was similar for diabetics and normal controls as a group, but was longer in patients with non-diabetic neuropathy than in normal controls (P=0.02). Diabetic patients with good glycemic control (HbA1c levels <7%) had longer RPs than patients with poorer glycemic control and normal controls (P=0.01). RP was longest at the HbA1c level of 6%, gradually decreasing and reaching a plateau at the HbA1c level of 8-9%.
Conclusions: Hyperglycemia shortens RPs, possibly because metabolic abnormalities lead to reduced nodal Na+ currents, and thereby to a lower inactivation of Na+ channels when generating an action potential.
Significance: RP measurements could provide new insights into the ionic pathophysiology of human diabetic neuropathy.
Roikjer J, Borbjerg M, Andresen T, Giordano R, Hviid C, Morch C J Diabetes Sci Technol. 2024; :19322968241279553.
PMID: 39282925 PMC: 11571639. DOI: 10.1177/19322968241279553.
Erol K, Topaloglu U, Gol M Turk J Phys Med Rehabil. 2022; 68(1):62-69.
PMID: 35949959 PMC: 9305650. DOI: 10.5606/tftrd.2022.6828.
The Pathological Links between Adiposity and the Carpal Tunnel Syndrome.
Otelea M, Nartea R, Popescu F, Covaleov A, Mitoiu B, Nica A Curr Issues Mol Biol. 2022; 44(6):2646-2663.
PMID: 35735622 PMC: 9221759. DOI: 10.3390/cimb44060181.
Metabolic Correction in Patients Sample with Diabetes: Clinical Outcomes and Costs Reductions.
Miranda-Massari J, Rodriguez-Gomez J, Gonzalez M, Cidre C, Duconge J, Marin H Int J Diabetes Res. 2017; 5(5):92-101.
PMID: 28936369 PMC: 5604848.
Entrapment neuropathies in diabetes mellitus.
Rota E, Morelli N World J Diabetes. 2016; 7(17):342-53.
PMID: 27660694 PMC: 5027001. DOI: 10.4239/wjd.v7.i17.342.